CSIMarket
 


Ocugen Inc   (OCGN)
Other Ticker:  
 
 

OCGN's Net Cash Flow Growth by Quarter and Year

Ocugen Inc 's Net Cash Flow results by quarter and year




OCGN Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -24.04 -12.39 4.93
III Quarter September -17.10 -13.40 -8.29 4.14
II Quarter June 2.32 -14.92 70.85 11.78
I Quarter March -9.30 34.81 20.75 -4.25
FY   -24.08 -17.55 70.92 16.60



OCGN Net Cash Flow third quarter 2023 Y/Y Growth Comment
Ocugen Inc in the third quarter 2023 recorded net cash outflow of $ -17.10 millions.

According to the results reported in the third quarter 2023, Ocugen Inc achieved the best Net Cash Flow growth in Biotechnology & Pharmaceuticals industry. While Ocugen Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the third quarter 2023.




OCGN Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -15.29 %
III Quarter September - - - -
II Quarter June - - 501.44 % -
I Quarter March - 67.76 % - -
FY   - - 327.23 % 185.22 %

Financial Statements
Ocugen Inc 's third quarter 2023 Net Cash Flow $ -17.10 millions OCGN's Income Statement
Ocugen Inc 's third quarter 2022 Net Cash Flow $ -13.40 millions Quarterly OCGN's Income Statement
New: More OCGN's historic Net Cash Flow Growth >>


OCGN Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - 19.08 %
III Quarter September - - - -64.86 %
II Quarter June - - 241.45 % -
I Quarter March - - 320.89 % -
FY (Year on Year)   - - 327.23 % 185.22 %




Net Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Ocugen Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OCGN's III. Quarter Q/Q Net Cash Flow Comment
III. Quarter 2023 net cash outflow of -17.10 millions by Ocugen Inc come out even less good if you take a look at 2.32 millions net cash outflow in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Ocugen Inc achieved highest sequential Net Cash Flow growth. While Ocugen Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OCGN's III. Quarter Q/Q Net Cash Flow Comment
Recent results of -17.10 millions by Ocugen Inc come out even worse considering the 2.32 millions net cash outflow in the second quarter.

Within Biotechnology & Pharmaceuticals industry Ocugen Inc achieved highest sequential Net Cash Flow growth. While Ocugen Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Ocugen Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Net Cash Flow 12 Months Ending $ -48.13 $ -44.43 $ -61.66 $ -17.55 $ -5.90
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
Ocugen Inc ' has realized cumulative trailing twelve months net cash outflow of $ -48 millions in the Sep 30 2023 period.
The results are worsening as the cumulative net cash outflow is becoming larger from $ -44.43 millions in TTM ending quarter Jun 30 2023 and $ -0.788 millions for the twelve months ending in the quarter Sep 30 2022.

Ocugen Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
Ocugen Inc ' has realized cumulative trailing twelve months net cash outflow of $ -48 millions in the Sep 30 2023 period.
The results are detiriorating as the cumulative net cash outflow is inflating from $ -44.43 millions in TTM ending quarter Jun 30 2023 and $ -0.788 millions from the TTM period ending Sep 30 2022.

Ocugen Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
OCGN's Net Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for OCGN's Competitors
Net Cash Flow Growth for Ocugen Inc 's Suppliers
Net Cash Flow Growth for OCGN's Customers

You may also want to know
OCGN's Annual Growth Rates OCGN's Profitability Ratios OCGN's Asset Turnover Ratio OCGN's Dividend Growth
OCGN's Roe OCGN's Valuation Ratios OCGN's Financial Strength Ratios OCGN's Dividend Payout Ratio
OCGN's Roa OCGN's Inventory Turnover Ratio OCGN's Growth Rates OCGN's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2023
Akili Inc 39.83%$ 39.834 millions
Monte Rosa Therapeutics Inc 38.64%$ 38.642 millions
Frequency Therapeutics Inc 37.00%$ 36.999 millions
Abbvie inc 36.76%$ 36.756 millions
Neptune Wellness Solutions Inc 35.13%$ 35.132 millions
3m Company29.33%$ 29.326 millions
Amicus Therapeutics inc 24.64%$ 24.638 millions
Stryker Corp22.07%$ 22.074 millions
Mersana Therapeutics Inc 18.07%$ 18.068 millions
Pacific Biosciences Of California Inc 15.91%$ 15.913 millions
Davita Inc 15.48%$ 15.476 millions
T2 Biosystems Inc 15.11%$ 15.110 millions
Harvard Bioscience Inc14.80%$ 14.802 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com